Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Aaron Cowen

Director at Benitec Biopharma Inc. (BNTC)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-25.4%
vs. S&P 500-17.6%
Beat the market0%
Paper profit on buys−$624K
Total bought / sold$1.9M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Dec 29SEC BNTCBenitec Biopharma Inc. Buy 42,6009,620,075 held (+0%) $12.85 $547K -31.0%
Dec 29SEC BNTCBenitec Biopharma Inc. Buy 7,4001,834,053 held (+0%) $12.85 $95K -31.0%
Dec 29SEC BNTCBenitec Biopharma Inc. Buy 14,3209,634,395 held (+0%) $13.10 $188K -32.3%
Dec 29SEC BNTCBenitec Biopharma Inc. Buy 2,5161,836,569 held (+0%) $13.10 $33K -32.3%
Dec 29SEC BNTCBenitec Biopharma Inc. Buy 65,8009,700,195 held (+1%) $13.44 $884K -34.0%
Dec 29SEC BNTCBenitec Biopharma Inc. Buy 11,5871,848,156 held (+1%) $13.44 $156K -34.0%
  • Buy

    Director Aaron Cowen bought $547K of BNTC at $12.85 — first open-market purchase in our records.

  • Buy

    Director Aaron Cowen bought $884K of BNTC at $13.44 — largest purchase by this insider in our records.